1 / 9

Professor Barry Kellman International Security & Biopolicy Institute

AN 8-STEP STRATEGY FOR BIOVIOLENCE MEDICAL COUNTERMEASURE (MCM) PREPAREDNESS BWC Meeting of Experts, 24 – 28 Aug., 2009. Professor Barry Kellman International Security & Biopolicy Institute. COORDINATE MCM R&D PLANNING. Establish an international biodefense task force to:

suki-reid
Download Presentation

Professor Barry Kellman International Security & Biopolicy Institute

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. AN 8-STEP STRATEGY FOR BIOVIOLENCE MEDICAL COUNTERMEASURE (MCM) PREPAREDNESSBWC Meeting of Experts, 24 – 28 Aug., 2009 Professor Barry Kellman International Security & Biopolicy Institute

  2. COORDINATE MCM R&D PLANNING • Establish an international biodefense task force to: • Advise on scientific and technical issues; identify hazards, probability of specific bioviolence attacks, and predictable consequences • Enhance information gathering regarding MCMs • Engage private sector in planning process

  3. STRENGTHEN, HARMONIZE MCM QUALITY STANDARDS • Adapt WHO “Good Manufacturing Principles” for bioviolence MCMs • Impel States to build capacity for complying with such standards • Incentives • Industrial inspection scheme

  4. HARMONIZE MCM LICENSING • International Conference on Harmonization (ICH) • Harmonizes national rules for regulatory processes by producing a single set of technical requirements for registering new drug products • WHO, UNICEF, UNFPA, World Bank, others: Model Quality Assurance System for Procurement Agencies • Focuses on prequalification of products and manufacturers; purchase; storage; and distribution • Global Harmonization Task Force (GHTF) • Build national regulatory licensing capacity for recognizing other States’ licensing decisions • Bi- and multi-lateral agreements among regulatory authorities to coordinate MCM approval processes

  5. HARMONIZE STANDARDS FOR MCM EMERGENCY USE AUTHORIZATION • State-legislated process to designate standards for emergency use of MCMs; standards should address: • Lethality of threat • Timeframe • Potential consequences of using unauthorized MCM • Dissemination strategies to lessen consequences • Availability of proposed MCM • Plan for use of unauthorized MCMs • Instruct response personnel re standards and methods of use • Track side effects and efficacy • Distribute treatments for known side effects of approved MCMs

  6. CLARIFY LEGAL RIGHTS OF MCM PRODUCERS • Harmonize standards for compulsory licensing of patented MCMs • Allow domestic producers to manufacture a patented item without the patent holder’s consent • Limited to meeting domestic needs, not for export; patent holder is to be paid adequate compensation • Harmonize standards for “fault” of the producer • Failure to accurately disclose risks during approval process • Substandard product delivered • Failure to provide sufficient use instructions

  7. DEVELOP INTERNATIONAL MCM STOCKPILING ARCHITECTURE • Assess, identify, and describe: • Location • of major cities and targets; degree of spread across States and regions; and proximity to transnational transportation networks • MCM procurement and surge capacities • Deployment tactics relevant to each agent • Stockpile content requirements based on threat assessment • Build upon, expand initiative of Global Health Security Action Group (GHSAG)

  8. PROMOTE MCM STOCKPILING SECURITY AND SURITY • Surety governs the proper storage and maintenance of stockpile assets. • Adapt WHO’s Guidelines on the International Packaging and Shipping of Vaccines to address specific challenges of bioviolence MCMs • Stockpile security • Site security: paramilitary forces, national guards, military personnel, local police forces. • Considerations: law enforcement, fire control, restricted areas, vehicle traffic, crowd control, coordination with local police • Training and exercises

  9. ENCOURAGE PLANNING FOR MCM DELIVERY • Develop model plans for • Command and control lines of responsibility • Define decisional hierarchies, timelines, and oversight modalities • Assign responsibilities for triggering MCM stockpile delivery • Distribution logistics • Select transportation methods and contingency options • Integrate with delivery of conventional medical supplies • Local readiness to receive MCMs • Select dispensation methodologies; instruct response personnel • Prepare major cities for local response (exercises) • Assist States to improve capacities to implement MCM delivery plans

More Related